Precipio Inc Receivables Turnover Ratio (PRPO), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Precipio inc   (NASDAQ: PRPO)
 

Precipio Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Precipio Inc 's ability to collect accounts receivable sequentially worsen to 13.25, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Precipio Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 28 days, from 26 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 80 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 772 to 843.

What is Receivable Turnover Ratio?
What is Precipio Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRPO Receivables Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Receivable Change 53.16 % 103.69 % 148.31 % 91.67 % 34.42 %
Y / Y Revenue Change 24.18 % 36.15 % 22.92 % 29.91 % 27.31 %
Receivable Turnover Ratio (TTM) 13.25 13.93 15.02 17.47 19.83
PRPO's Total Ranking # 843 # 772 # 644 # 646 # 548
Accounts Receivable average collection period days 28 26 24 21 18
Seq. Receivable Change 14.64 % 0.2 % 1.38 % 31.52 % 52.46 %
Seq. Revenue Change 4.62 % 0.18 % -1 % 19.69 % 14.71 %


Receivable Turnover Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 1
Healthcare Sector # 81
Overall Market # 843

Receivable Turnover Ratio Statistics
High Average Low
20.53 7.85 2.04
(Mar 31 2025)   (Jun 30 2016)





PRPO Company Profile • Back to PRPO Efficiency Comparisons • Compare PRPO Receivables Turnover Ratio to its Competitors

Financial Statements
Precipio Inc 's Accounts Receivable $ 2 Millions Visit PRPO's Balance sheet
Precipio Inc 's Sales TTM $ 27 Millions Visit PRPO's Income Statement
Sources of PRPO's Revenues Visit PRPO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PRPO's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PRPO's Growth Rates PRPO's Roa PRPO's Inventory Turnover Ratio PRPO's Dividend Comparisons
PRPO's Profitability Ratios PRPO's Roi PRPO's Asset Turnover Ratio PRPO's Dividend Growth
PRPO's Valuation Ratios PRPO's Roe PRPO's Financial Strength Ratios PRPO's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Innovative Eyewear Inc   31.49 $ 3.412  Millions$ 0.108  Millions
Cv Sciences Inc   31.22 $ 12.066  Millions$ 0.387  Millions
Ginkgo Bioworks Holdings Inc   30.60 $ 111.863  Millions$ 3.656  Millions
Innovage Holding Corp   30.33 $ 989.707  Millions$ 32.630  Millions
Invo Fertility Inc   30.20 $ 7.531  Millions$ 0.249  Millions
Wave Life Sciences Ltd   26.88 $ 81.746  Millions$ 3.041  Millions
Igc Pharma Inc   26.21 $ 1.101  Millions$ 0.042  Millions
Sonida Senior Living Inc   23.90 $ 525.973  Millions$ 22.008  Millions
Marpai Inc  23.52 $ 16.635  Millions$ 0.707  Millions
Agenus Inc  22.44 $ 132.693  Millions$ 5.914  Millions
U S Physical Therapy Inc  22.40 $ 812.203  Millions$ 36.251  Millions
Nutriband Inc   22.15 $ 1.618  Millions$ 0.073  Millions
Lineage Cell Therapeutics Inc   20.02 $ 13.083  Millions$ 0.654  Millions
Hims and Hers Health Inc   19.65 $ 2,578.494  Millions$ 131.228  Millions
Neuraxis Inc   18.95 $ 5.316  Millions$ 0.281  Millions
China Pharma Holdings Inc  18.55 $ 3.914  Millions$ 0.211  Millions
Bausch Health Companies Inc   18.42 $ 10,853.000  Millions$ 589.250  Millions
Arvinas Inc   17.26 $ 316.700  Millions$ 18.350  Millions
Nrx Pharmaceuticals Inc   17.25 $ 3.394  Millions$ 0.197  Millions
Polomar Health Services, Inc.  17.19 $ 3.172  Millions$ 0.185  Millions
Escalon Medical Corp   16.86 $ 12.736  Millions$ 0.756  Millions
Anika Therapeutics Inc   16.70 $ 121.370  Millions$ 7.266  Millions
Lifemd Inc   16.48 $ 163.363  Millions$ 9.915  Millions
Longeveron Inc   16.43 $ 1.187  Millions$ 0.072  Millions
Bioage Labs Inc   15.82 $ 10.355  Millions$ 0.655  Millions
Vaxart Inc   15.09 $ 243.064  Millions$ 16.108  Millions
Medicinova Inc   15.02 $ 0.920  Millions$ 0.061  Millions
Voyager Therapeutics Inc   14.71 $ 34.459  Millions$ 2.343  Millions
Halozyme Therapeutics Inc   14.68 $ 1,663.738  Millions$ 113.332  Millions
Nexgel Inc   14.52 $ 11.810  Millions$ 0.813  Millions

Date modified: 2026-10-05T11:03:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.